Blood test study for cervical cancer biomarkers
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is looking for markers in the blood of people with cervical cancer that might help doctors choose the best treatment. It is a feasibility study, meaning it aims to find out if this approach works before a larger trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman, 18 years or older.
- You have been diagnosed with squamous cell carcinoma or adenocarcinoma of the cervix, at any stage from 1a to 4b.
- You are about to start intensive treatment such as surgery, radiation therapy, or a combination of chemotherapy and radiation.
- You have not had another cancer in the last 5 years, except for certain cured skin cancers or ductal carcinoma in situ.
- You are willing to sign a consent form to confirm you understand the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
This study looks at whether simple blood tests can help predict how well first-line treatment works for cervical cancer that has come back or spread. It aims to improve future care by tracking changes in the blood over time.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
Hear when a new Cervical Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.